Roche is hoping new data will help its cancer immunotherapy Tecentriq gain more traction, and prolong the shelf-life of its older cancer medicine Avastin. The Swiss pharma company revealed phase 3 ...

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...

Your guide to all things theatre on Broadway and around the world including shows, news, reviews, broadway tickets, regional theatre and more.

A US jury has decided that Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu infringes a patent held by US biotech Seagen, awarding almost $42 million in damages. Seagen claims Enhertu ...

The track appears on her latest EP, "Nashville Canyon, Pt. 2." John Varvatos pieces can take you from a meal to a mosh pit and everywhere in between, and the brand ...